ArticleFrontiers in genetics2022

An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas.

Wei Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.